Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-16T19:39:51.822Z Has data issue: false hasContentIssue false

1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease

Published online by Cambridge University Press:  13 November 2002

KEJAL KANTARCI
Affiliation:
Department of Diagnostic Radiology, Mayo Clinic, Rochester, Minnesota
GLENN E. SMITH
Affiliation:
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota Alzheimer's Disease Research Center, Mayo Clinic, Rochester, Minnesota
ROBERT J. IVNIK
Affiliation:
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota Alzheimer's Disease Research Center, Mayo Clinic, Rochester, Minnesota
RONALD C. PETERSEN
Affiliation:
Alzheimer's Disease Research Center, Mayo Clinic, Rochester, Minnesota Department of Neurology, Mayo Clinic, Rochester, Minnesota
BRADLEY F. BOEVE
Affiliation:
Alzheimer's Disease Research Center, Mayo Clinic, Rochester, Minnesota Department of Neurology, Mayo Clinic, Rochester, Minnesota
DAVID S. KNOPMAN
Affiliation:
Alzheimer's Disease Research Center, Mayo Clinic, Rochester, Minnesota Department of Neurology, Mayo Clinic, Rochester, Minnesota
ERIC G. TANGALOS
Affiliation:
Alzheimer's Disease Research Center, Mayo Clinic, Rochester, Minnesota Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
CLIFFORD R. JACK
Affiliation:
Department of Diagnostic Radiology, Mayo Clinic, Rochester, Minnesota Alzheimer's Disease Research Center, Mayo Clinic, Rochester, Minnesota

Abstract

The aim of this study was to examine the associations of apolipoprotein E (APOE) genotype, metabolic changes in the posterior cingulate detected by 1H magnetic resonance spectroscopy (MRS), and neuropsychologic measures of memory and cognition both in normally aging elderly, and in patients with mild cognitive impairment (MCI) and AD. We studied 67 controls, 18 MCI and 33 AD patients. We used the Dementia Rating Scale total score (DRSTOT) as a measure of general cognitive function and the total learning from the Auditory Verbal Learning Test (AVTOT) as a measure of memory performance. No differences were noted on 1H-MRS metabolite ratios or cognitive measures across APOE genotype within control and patient groups. In controls, age was a significant predictor of both cognitive test scores, and NAA/Cr was a univariate associate of DRSTOT. All 3 1H-MRS metabolite ratios, N-acetylaspartate (NAA)/creatine (Cr), myoinositol (MI)/Cr, and NAA/MI, were univariate associates of AVTOT and DRSTOT scores in the combined MCI and AD group. In stepwise regression analyses in the combined patient group only NAA/MI entered the models. These data suggest NAA/Cr could be a modest predictor of general cognitive function in both healthy elderly and impaired patients, while MI/Cr is a more specific marker for neuropsychologic dysfunction associated with neurodegenerative disease. Among 1H-MRS measurements, the NAA/MI ratio maybe the most efficient predictor of memory and cognitive function in patients with MCI and AD. (JINS, 2002, 8, 934–942.)

Type
Research Article
Copyright
© 2002 The International Neuropsychological Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)